• Antitussive and expectorant treatment with acute respiratory diseases in children 
To content

Antitussive and expectorant treatment with acute respiratory diseases in children 

SOVREMENNAYA PEDIATRIYA.2015.6(70):51-55; doi 10.15574/SP.2015.70.51 
 

Antitussive and expectorant treatment with acute respiratory diseases in children 
 

Marushko Iu., Gischak Т., Lysovetz О., Muka M., Marushko E.

National Bogomolets Medical University 
 

Cough is a nonspecific defense mechanism during ARI, which under certain conditions may become of inadequate intensiveness, intrusive and impair the general condition of the patient. In the above case, the cough becomes a separate problem for the patient, and needs pathogenetic and symptomatic therapy. Expectorant stepwise therapy with Pectolvan Stop with further transition to drug Pectolvan Hedera is adequate scheme that takes into account the different stages of the respiratory system mucous membrane reaction on infectious lesions. 
 

Key words: cough, expectorant therapy, children. 
 

References

1. Баранов АА. 2009. Педиатрия. Национальное руководство. 2-х т. Москва, ГЭОТАР-Медиа.

2. Інструкція застосування препарату Пектолван Стоп (наказ МОК України № 386 від 06.05.2010).

3. Ревякина ВА. 2006. Кашель у детей: причины и подходы к терапии. Педиатрия. 2: 12-14.

4. Таточенко ВК. 2008. Дифференциальная диагностика кашля у детей и его лечение. Лечащий врач. 3: 13—15.

5. Goldsobel AB, Chipps BE. 2010. Cough in the Pediatric Population. The Journal of Pediatrics. 156;3: 352—358. http://dx.doi.org/10.1016/j.jpeds.2009.12.004; PMid:20176183

6. Hay AD, Wilson A, Fahey T, Peters TJ. 2003. The duration of acute cough in preschool children presenting to primary care: a prospective cohort study. Family Practice. 20: 696—705. http://dx.doi.org/10.1093/fampra/cmg613; PMid:14701895